Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin, Axantia collaborate for Pegfilgrastim

Ruchika Sharma2 Feb 2022 11:09 AM IST

Mumbai: Global pharma major, Lupin Limited, has recently announced that they have entered into a License, Supply and Technology Sharing agreement with...

Zydus Wellness net profit rises 1239.08 percent in Q3

Ruchika Sharma2 Feb 2022 9:30 AM IST

Ahmedabad: Zydus Wellness Ltd., has recently announced results for the third quarter ended 31st December, 2021. The Company reported consolidated Net...

Alembic Pharma Clarithromycin tablets get USFDA okay

Ruchika Sharma1 Feb 2022 3:48 PM IST

Vadodara: Drug maker, Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...

Roche gets USFDA nod for injectable eye medicine Vabysmo

Ruchika Sharma1 Feb 2022 1:37 PM IST

Basel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has approved Vabysmo (faricimab-svoa) for the treatment of...

Novavax seeks USFDA emergency use nod for COVID vaccine

Ruchika Sharma1 Feb 2022 11:51 AM IST

Gaithersburg: Novavax, Inc has recently announced that the company has submitted a request to the U.S Food and Drug Administration (USFDA) for...

Moderna bags full USFDA nod for COVID vaccine Spikevax

Ruchika Sharma1 Feb 2022 11:04 AM IST

Cambridge: Moderna, Inc. has recently announced the U.S. Food and Drug Administration (USFDA) has approved the Biologics License Application (BLA) for...

Sanofi, Regeneron get CHMP recommendation for Dupixent approval to treat severe asthma with type 2 inflammation in kids

Ruchika Sharma1 Feb 2022 10:00 AM IST

Paris: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Medicines Agency's Committee for Medicinal Products for Human...

Sun Pharma net profit rises 11 percent to Rs 2,058.8 crore in Q3

Ruchika Sharma1 Feb 2022 9:30 AM IST

New Delhi: Sun Pharma on Monday posted an 11.14 per cent increase in its consolidated net profit to Rs 2,058.8 crore for the third quarter ended on...

AstraZeneca in soup over suspected medical insurance fraud

Ruchika Sharma31 Jan 2022 1:54 PM IST

The company has taken disciplinary action against those employees and has reported their violations to the authorities, the statement said.

Granules India arm gets 3 USFDA observations for Chantilly facility

Ruchika Sharma31 Jan 2022 1:02 PM IST

Hyderabad: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in...

Indian pharma sector FDI sees sudden spurt in 2020-21: Survey

Ruchika Sharma31 Jan 2022 12:30 PM IST

New Delhi: Foreign direct investment in India's pharmaceutical sector saw a "sudden spurt" in 2020-21 mainly on account of investments to meet...

Pre-budget survey shows increasing demand for making investments more attractive in pharma sector

Ruchika Sharma31 Jan 2022 11:45 AM IST

New Delhi: A pre-budget expectations survey showed increasing demand for making investments more attractive in the pharmaceutical industry.As per the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok